Qinghai Spring Medicinal Resources Technology Co., Ltd. research and development, production, and sale of cordyceps products. It is also involved in the sale of beverages and aquatic products; advertising; and foreign investment business. The company was founded in 2003 and is based in Xining, China.
Qinghai Spring Medicinal Resources Technology Dividend Announcement
• Qinghai Spring Medicinal Resources Technology announced a annually dividend of ¥0.05 per ordinary share which will be made payable on . Ex dividend date: 2003-05-21
• Qinghai Spring Medicinal Resources Technology's trailing twelve-month (TTM) dividend yield is -%
Qinghai Spring Medicinal Resources Technology Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2003-05-21 | ¥0.05 | annually | |
| 2002-07-05 | ¥0.05 | annually |
Qinghai Spring Medicinal Resources Technology Dividend per year
Qinghai Spring Medicinal Resources Technology Dividend Yield
Qinghai Spring Medicinal Resources Technology current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Qinghai Spring Medicinal Resources Technology stock? Use our calculator to estimate your expected dividend yield:
Qinghai Spring Medicinal Resources Technology Financial Ratios
P/E ratio-6.55
PEG ratio0.03
P/B ratio1.65
ROE-23.82%
Payout ratio0.00%
Current ratio10.73
Quick ratio7.06
Cash Ratio2.50
Qinghai Spring Medicinal Resources Technology Dividend FAQ
Does Qinghai Spring Medicinal Resources Technology stock pay dividends?
Qinghai Spring Medicinal Resources Technology does not currently pay dividends to its shareholders.
Has Qinghai Spring Medicinal Resources Technology ever paid a dividend?
No, Qinghai Spring Medicinal Resources Technology has no a history of paying dividends to its shareholders. Qinghai Spring Medicinal Resources Technology is not known for its dividend payments.
Why doesn't Qinghai Spring Medicinal Resources Technology pay dividends?
There are several potential reasons why Qinghai Spring Medicinal Resources Technology would choose not to pay dividends to their shareholders:
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Qinghai Spring Medicinal Resources Technology ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Qinghai Spring Medicinal Resources Technology has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Qinghai Spring Medicinal Resources Technology a dividend aristocrat?
Qinghai Spring Medicinal Resources Technology is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Qinghai Spring Medicinal Resources Technology a dividend king?
Qinghai Spring Medicinal Resources Technology is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Qinghai Spring Medicinal Resources Technology a dividend stock?
No, Qinghai Spring Medicinal Resources Technology is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Qinghai Spring Medicinal Resources Technology stocks?
To buy Qinghai Spring Medicinal Resources Technology you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.
Place an order: Use the brokerage's trading platform to place an order to buy Qinghai Spring Medicinal Resources Technology stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy Qinghai Spring Medicinal Resources Technology stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.